paroxetine has been researched along with Stroke in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, L; Crépin, P; Del Cul, A; El Hachem, R; Guérineau de Lamérie, G; Kas, A; Morin, A; Ponchel, A; Ströer, S | 1 |
| Han, L; Han, Z; Li, L; Yan, B | 1 |
| Campbell Burton, CA; Chun, HY; Gillespie, D; Holmes, J; Knapp, P; Lewis, SR; Lightbody, CE; Murray, J; Watkins, CL | 1 |
| Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C | 1 |
| Li, P; Ma, C | 1 |
| Chen, W; Geng, D; Huang, Y; Li, Y; Shi, X; Wu, X | 1 |
| Chino, A; Kasahara, Y; Namiki, T; Ogawa, K; Okamoto, H; Terasawa, K; Ueda, K | 1 |
| Campbell Burton, CA; Gillespie, D; Holmes, J; Knapp, P; Lightbody, CE; Murray, J; Watkins, CL | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Christensen, J; Clemmensen, PM; Dalsgaard, NJ; Dam, H; Hindberg, I; Lunde, M; Mellerup, E; Plenge, P; Rasmussen, A | 1 |
| Ramasubbu, R | 2 |
| de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P | 1 |
| Andor, G; Harcos, P; Horváth, S; Karányi, Z; Nagy, Z; Németh, G | 1 |
| Erfurth, A; Floreanu, A; Loew, M; Wendler, G | 1 |
| Devarajan, S; Dursun, SM; Haddad, PM | 1 |
| Antonucci, G; Bragoni, M; Coiro, P; De Angelis, D; Grasso, MG; Morelli, D; Paolucci, S; Rizzi, F; Troisi, E | 1 |
5 review(s) available for paroxetine and Stroke
| Article | Year |
|---|---|
Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
Topics: Affect; Antidepressive Agents, Second-Generation; Depression; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stroke; Time Factors; Treatment Outcome | 2020 |
Interventions for treating anxiety after stroke.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Depression; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychotherapy; Randomized Controlled Trials as Topic; Relaxation Therapy; Stroke | 2017 |
Interventions for treating anxiety after stroke.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Humans; Paroxetine; Psychotherapy; Randomized Controlled Trials as Topic; Stroke | 2011 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem | 2007 |
2 trial(s) available for paroxetine and Stroke
| Article | Year |
|---|---|
Platelet serotonin transporter in stroke patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Binding, Competitive; Biomarkers; Blood Platelets; Carrier Proteins; Chronic Disease; Depression; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; Serotonin Plasma Membrane Transport Proteins; Stroke; Time Factors | 2003 |
[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression; Female; Follow-Up Studies; Humans; Hungary; Male; Middle Aged; Paroxetine; Prevalence; Quality of Life; Selective Serotonin Reuptake Inhibitors; Stroke; Time Factors; Treatment Outcome | 2006 |
10 other study(ies) available for paroxetine and Stroke
| Article | Year |
|---|---|
Recovery from cortical blindness with mepivacaïne.
Topics: Blindness, Cortical; Brain; Cerebral Cortex; Humans; Magnetic Resonance Imaging; Male; Mepivacaine; Middle Aged; Paroxetine; Stroke | 2019 |
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome | 2017 |
Effectiveness of paroxetine in the treatment of poststroke depression.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Retrospective Studies; Stroke; Treatment Outcome | 2018 |
Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Aspartic Acid; Brain Mapping; Case-Control Studies; Choline; Depression; Dose-Response Relationship, Drug; Female; Functional Laterality; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Paroxetine; Stroke; Thalamus; Tritium | 2010 |
A case of thalamic pain successfully treated with Kampo medicine.
Topics: Aged; Analgesics; Diazepam; Female; Humans; Infarction; Medicine, Kampo; Movement Disorders; Nausea; Pain; Paroxetine; Phytotherapy; Plant Extracts; Sensation Disorders; Stroke; Thalamus | 2011 |
Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Severity of Illness Index; Stroke; Substance Withdrawal Syndrome | 2003 |
Antidepressant treatment-associated behavioural expression of hypomania: a case series.
Topics: Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Irritable Mood; Ischemic Attack, Transient; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Stroke | 2004 |
[Depressive disorders in neurologic rehabilitation: therapy with paroxetine].
Topics: Adult; Aged; Brain Diseases; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Stroke; Stroke Rehabilitation; Treatment Outcome | 2001 |
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |
Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.
Topics: Activities of Daily Living; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; Depression; Disabled Persons; Female; Fluoxetine; Humans; Male; Middle Aged; Motor Activity; Paroxetine; Recovery of Function; Stroke; Stroke Rehabilitation | 2001 |